Affin Hwang maintains hold on IHH Healthcare, trims target to RM6.56


AmInvestment has a fair value of RM7.20 a share for IHH Healthcare Bhd

KUALA LUMPUR: Affin Hwang Capital Research is positive on IHH Healthcare Bhd’s venture into new markets.

However, the research house said IHH’s near-term earnings could be dampened by losses from the opening of new hospitals and hiccups from consolidation of newly-acquired entities.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

OCK proposed RM500mil ICP programme
Profit-taking in the market, KLCI down 0.14%
EPF balancing between retirement mandate and supporting members' economic survival
Asian stocks hit by US tech slide, FX subdued
CelcomDigi emphasises its significant role in protecting customers from AI-related risks
China's largest auto show showcases all-electric future, local brands dominate
Unilever beats first quarter sales forecasts, sticks to 2024 outlook
Oil steady as market weighs US demand concerns, Middle East conflict risks
HeiTech Padu targets stronger earnings growth after returning to black in 2023
PBOC may up bond trading

Others Also Read